TY  - GEN
AU  - Chancellor,J V
AU  - Hunsche,E
AU  - de Cruz,E
AU  - Sarasin,F P
TI  - Economic evaluation of celecoxib, a new cyclo-oxygenase 2 specific inhibitor, in Switzerland
SN  - 1170-7690
PY  - 2001///0412
KW  - Anemia
KW  - chemically induced
KW  - Anti-Inflammatory Agents, Non-Steroidal
KW  - adverse effects
KW  - Anti-Ulcer Agents
KW  - economics
KW  - Arthritis
KW  - drug therapy
KW  - Celecoxib
KW  - Clinical Trials as Topic
KW  - Cost of Illness
KW  - Cost-Benefit Analysis
KW  - Cyclooxygenase Inhibitors
KW  - Decision Trees
KW  - Drug Therapy, Combination
KW  - Duodenal Ulcer
KW  - Economics, Pharmaceutical
KW  - Humans
KW  - Probability
KW  - Pyrazoles
KW  - Sulfonamides
KW  - Switzerland
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.2165/00019053-200119001-00005
ER  -